Stereochemical studies on medicinal agents. 25. Absolute configuration and analgetic potency of .beta.-1,2-dimethyl-4-phenyl-4-(propionyloxy)piperidine enantiomers

Journal of Medicinal Chemistry
1982.0

Abstract

Enantiomers of beta-1,2-dimethyl-4-phenyl-4-(propionyloxy)piperidine (4) were employed as probes to demonstrate that opioid receptors are capable of distinguishing between the enantiotopic edges (the Ogston effect) of the piperidine ring. These enantiomers, (-)- and (+)-4.HCl, were prepared by esterification of the corresponding alcohols, (+)- and (-)-4a. Single crystal X-ray studies of (-)-4a.HCl reveal that it possesses the 2R,4S absolute configuration. Analgetic testing in mice (hot-plate) and receptor binding studies indicate that (-)-(2S,4R)-4.HCl is approximately ten times more potent than its enantiomer. The results are consistent with the operation of the Ogston effect in the interaction of achiral 4-phenylpiperidines with opioid receptors. Additionally, it is suggested that the piperidine ring of these and other closely related 4-phenylpiperidines bind within a receptor subsite cleft whose dimensions exclude diequatorial 2,6- and 3,5-dimethyl-substituted ligands.

Knowledge Graph

Similar Paper

Stereochemical studies on medicinal agents. 25. Absolute configuration and analgetic potency of .beta.-1,2-dimethyl-4-phenyl-4-(propionyloxy)piperidine enantiomers
Journal of Medicinal Chemistry 1982.0
N-Substituent modulation of opiate agonist/antagonist activity in resolved 3-methyl-3-(m-hydroxyphenyl)piperidines
Journal of Medicinal Chemistry 1986.0
Synthesis and dopaminergic properties of the two enantiomers of 3-(3,4-dimethylphenyl)-1-propylpiperidine, a potent and selective dopamine D4 receptor ligand
Bioorganic & Medicinal Chemistry Letters 2001.0
Enantiomers of Diastereomeric cis-N-[1-(2-Hydroxy-2-phenylethyl)-3-methyl-4-piperidyl]-N-phenylpropanamides: Synthesis, X-ray Analysis, and Biological Activities
Journal of Medicinal Chemistry 1995.0
Synthesis, x-ray crystallographic determination, and opioid activity of erythro-5-methylmethadone enantiomers. Evidence which suggests that .mu. and .delta. opioid receptors possess different stereochemical requirements
Journal of Medicinal Chemistry 1982.0
Synthesis and structure-activity relationships of 1-substituted 4-(1,2-diphenylethyl)piperazine derivatives having narcotic agonist and antagonist activity
Journal of Medicinal Chemistry 1987.0
Structure-activity relationships of trans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidine antagonists for .mu.- and .kappa.-opioid receptors
Journal of Medicinal Chemistry 1993.0
Combined analgesic/neuroleptic activity in N-butyrophenone prodine-like compounds
Journal of Medicinal Chemistry 1987.0
Absolute stereochemistry and dopaminergic activity of enantiomers of 2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine
Journal of Medicinal Chemistry 1982.0
Phenylmorphans and analogs: opioid receptor subtype selectivity and effect of conformation on activity
Journal of Medicinal Chemistry 1992.0